View Author
screening cancer prostate cancer prostate study control arm control treatment group erspc round screening arm centre death european effect screening round trial mortality european randomized study follow-up reduction result number randomized analysis disease diagnosis incidence table value center interval control group stage urology contamination roobol therapy screening group biopsy schr öder fh detection rotterdam prostate-cancer difference randomised period university screen gleason ratio schroder cancer detection rate nejm.org model subject men randomised study arm roobol mj psa value england journal characteristic department journal medicine downloaded tumour characteristics erasmus university prostate cancer screening finland european randomised study netherland koning hj estimate 69 years score sweden 1000 men core age group radiotherapy
7 Most Recent Publications
|
Screening for prostate cancer decreases the risk of developing metastatic disease: Findings from the European Randomized Study of Screening for Prostate Cancer (ERSPC)
(Article)
Schröder, F.H. Hugosson, J. Carlsson, S. Tammela, T.L. Määttänen, L. Auvinen, A. Kwiatkowski, M. Recker, F. Roobol, M.J. |
2012-11-01
|
|
Quality-of-life effects of prostate-specific antigen screening
(Article)
Heijnsdijk, E.A.M. Wever, E.M. Zappa, M. Tammela, T.L. Mäkinen, T. Carlsson, S. Korfage, I.J. Essink-Bot, M.L.E. Otto, S.J. Draisma, G. Bangma, C.H. Roobol, M.J. Auvinen, A. Schröder, F.H. Koning, H.J. de Hugosson, J. Ciatto, S. Nelen, V. Kwiatkowski, M. Villers, A. Páez, A. Moss, S.M. |
2012-08-16
|
|
Change of tumour characteristics and treatment over time in both arms of the European Randomized study of Screening for Prostate Cancer
(Article)
Boevee, S.J. Venderbos, L.D.F. Tammela, T.L. Nelen, V. Ciatto, S. Kwiatkowski, M. Páez, A. Malavaud, B. Hugosson, J. Roobol, M.J. |
2010-11-01
|
|
PSA levels and cancer detection rate by centre in the European Randomized Study of Screening for Prostate Cancer
(Article)
Otto, S.J. Moss, S.M. Koning, H.J. de Määttänen, L. Roobol, M.J. Zappa, M. Nelen, V. Kwiatkowski, M. Villers, A. Hugosson, J. Sanchez, A. |
2010-11-01
|
|
The effect of study arm on prostate cancer treatment in the large screening trial ERSPC
(Article)
Wolters, T. Roobol, M.J. Nelen, V. Tammela, T.L. Schröder, F.H. Steyerberg, E.W. Bergh, R.C.N. van den Bangma, C.H. Hugosson, J. Ciatto, S. Kwiatkowski, M. Villers, A. Lujan, M. |
2010-05-15
|
|
Prostate Cancer Mortality Reduction by Prostate-Specific Antigen-Based Screening Adjusted for Nonattendance and Contamination in the European Randomised Study of Screening for Prostate Cancer (ERSPC)
(Article)
Roobol, M.J. Kerkhof, M. Lujan, M. Lilja, H. Zappa, M. Denis, L.J. Recker, F. Berenguer, A. Ruutu, M. Kujala, P.M. Bangma, C.H. Aus, G. Schröder, F.H. Tammela, T.L. Villers, A. Rébillard, X. Moss, S.M. Koning, H.J. de Hugosson, J. Auvinen, A. Cuzick, J. Sasieni, P. Hakama, M. Stenman, U.H. Ciatto, S. Nelen, V. Kwiatkowski, M. |
2009-10-01
|
|
Screening and prostate-cancer mortality in a randomized european study
(Article)
Schröder, F.H. Hugosson, J. Denis, L.J. Recker, F. Määpttänen, A.B. Bangma, C.H. Aus, G. Villers, A. Rébillard, X. Kwast, Th.H. van der Blijenberg, B.G. Moss, S.M. Roobol, M.J. Koning, H.J. de Auvinen, A. Tammela, T.L. Ciatto, S. Nelen, V. Kwiatkowski, M. Lujan, M. Lilja, H. Zappa, M. |
2009-03-26
|
